Cardinal Partners


	Momenta Pharmaceuticals Provides Update Regarding Generic Lovenox(R) Litigation
	July 27, 2010
	Momenta Pharmaceuticals Announces Conference Call Details Regarding Approval for Generic Lovenox(R)
	July 23, 2010
	Cubist Pharmaceuticals to Ring the NASDAQ Stock Market Opening Bell
	July 19, 2010
	Alnylam to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of Transthyretin-Mediated Amyloidosis
	July 19, 2010
	athenahealth Responds to 'Meaningful Use' Requirements for EHRs: Extends Deadline for Participation in Federal Stimulus Bonus Payment Guarantee Program for Physicians Nationwide
	July 15, 2010
	Cubist Announces Objectives Met in Phase 2 Safety Study of CUBICIN in Prosthetic Joint Infections
	July 13, 2010
	athenahealth Achieves Preliminary Interim Final Rule (IFR) Stage 1 EHR Certification from CCHIT
	July 09, 2010
	Alnylam Initiates Dosing in Phase I Clinical Study of ALN-TTR01 in Patients with Transthyretin-Mediated Amyloidosis (ATTR)
	July 07, 2010
	athenahealth, Inc. Appoints Dev Ittycheria to Board of Directors
	July 07, 2010
	VHA Signs Agreement with athenahealth Bringing EHR and Practice Management Services to its Physician Network
	July 07, 2010
	Alnylam Obtains Approvals to Initiate Phase I Study with ALN-TTR01 in Patients with TTR-Mediated Amyloidosis (ATTR)
	June 29, 2010
	Cubist Pharmaceuticals Enrolls First Patient in CXA-201 Phase 2 Study in Complicated Intra-Abdominal Infections
	June 29, 2010
	Cubist Announces All Objectives Met in Phase 2 CXA-101 Complicated Urinary Tract Infections Study
	June 29, 2010
	Alnylam Scientists and Collaborators Publish Research in Nature Chemical Biology on a Novel Mechanism for Regulation of Gene Expression with Anti-Gene RNAs (agRNAs)
	June 28, 2010
	athenaClinicals Selected as EHR Partner for Virginia Regional Extension Center
	June 25, 2010
	Alnylam Biotherapeutics Presents New Data on RNAi Applications in Biotherapeutics Manufacturing
	June 23, 2010
	Sanofi-Aventis and Regulus Therapeutics Form Major Strategic Alliance on microRNA Therapeutics
	June 22, 2010
	Isis and Alnylam Provide Update on Regulus' Strategic Alliance with Sanofi-Aventis
	June 20, 2010
	Alnylam Secures Intellectual Property and Technology for RNAi Applications in Vaccine Research and Development
	June 17, 2010
	Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics that Target Mutated Genes
	June 17, 2010
	Alnylam to Webcast Presentation at the 5th Annual Piper Jaffray Europe Conference
	June 16, 2010
	aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
	June 14, 2010
	Cubist Pharmaceuticals to Oppose Teva’s Attempt to Add Inequitable Conduct Defense in Patent Infringement Action
	June 11, 2010
	Momenta Pharmaceuticals to Present at Goldman Sachs 31st Annual Global Healthcare Conference
	June 11, 2010
	Cubist Pharmaceuticals Receives Claim Construction Order in Patent Infringement Action Against Teva Parenteral Medicines, Inc.
	June 08, 2010
	Alnylam Presents Preliminary Phase I Data at American Society of Clinical Oncology (ASCO) Meeting for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers
	June 07, 2010
	Alnylam to Webcast Presentation at the 9th Annual Needham Healthcare Conference
	June 07, 2010
	athenahealth Announces Management Changes
	June 04, 2010
	Markman Hearing Cancelled in Cubist Pharmaceuticals’ Patent Infringement Action Against Teva Parenteral Medicines, Inc.
	June 04, 2010
	Alnylam Biotherapeutics Forms Scientific Advisory Board
	June 03, 2010
	Alnylam Strengthens Management Team with New Key Appointments
	June 02, 2010
	Momenta Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
	June 02, 2010
	Alnylam and Collaborators Discover New Class of Small RNAs in Flu
	June 01, 2010
	Regulus Therapeutics Receives Exclusive License for Intellectual Property to microRNA-21 for Diseases of the Heart, Liver, and Kidney
	May 27, 2010
	Cubist Pharmaceuticals to Present at June 2010 Investor Conferences
	May 26, 2010
	Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
	May 25, 2010
	Momenta Pharmaceuticals Announces Date for 2010 Annual Meeting of Stockholders
	May 20, 2010
	Alnylam's ALN-VSP Abstract Published by American Society of Clinical Oncology (ASCO)
	May 20, 2010
	European Patent Office Appeal Board Rules in Favor of Alnylam's Kreutzer-Limmer Patent
	May 19, 2010
	U.S. Patent and Trademark Office Grants athenahealth a Patent for its Automated Implementation System for Medical Practice Management Services
	May 19, 2010
	Alnylam to Webcast Presentations at the Rodman & Renshaw 6th Annual Global Healthcare Conference and the Baird 2010 Growth Stock Conference
	May 12, 2010
	Markman Hearing in CUBICIN® Patent Litigation Rescheduled to June 9, 2010
	May 12, 2010
	Alnylam Scientists and Collaborators Publish Research on Key Mechanism for Delivery of RNAi Therapeutics with Lipid Nanoparticles (LNPs)
	May 11, 2010
	Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2010
	May 06, 2010
	Alnylam Pharmaceuticals Reports First Quarter 2010 Financial Results
	May 05, 2010
	Massachusetts Institute of Technology (MIT) Joins Pool for Open Innovation against Neglected Tropical Diseases
	May 05, 2010
	Alnylam Receives Intent to Grant by European Patent Office for New Patent Broadly Covering RNAi Therapeutics
	May 03, 2010
	RIB-X TO PRESENT AT RIBOSOMES 2010 CONFERENCE
	May 03, 2010
	Alnylam and Collaborators at CNRS - Université de Montpellier Publish Paper on Novel Synthetic Method for Bi-functional 3p-siRNAs
	April 30, 2010
	Cubist Pharmaceuticals to Present at May 2010 Investor Conferences
	April 30, 2010
	Awarepoint Announces Management Restructuring and the Opening of Its New Headquarters in the Heart of Downtown San Diego
	April 29, 2010
	athenahealth, Inc. Reports First Quarter Fiscal Year 2010 Results
	April 29, 2010
	Alnylam Named to The ScientistMagazine's 2010 Best Places to Work in Industry
	April 29, 2010
	Alnylam to Webcast Conference Call Discussing First Quarter 2010 Financial Results
	April 29, 2010
	Lourdes Medical Associates Selects athenahealth's Revenue Cycle Management Service For Growing Physician Network
	April 28, 2010
	Alnylam Biotherapeutics Presents New Results on Use of RNAi Technologies for Biotherapeutics Manufacturing
	April 28, 2010
	Alnylam Publishes Results from Phase II GEMINI Trial with ALN-RSV01
	April 27, 2010
	Novartis Exercises its Right to Purchase Additional Shares of Alnylam Common Stock
	April 26, 2010
	Alnylam and Collaborators Demonstrate Regression of Pathogenic Transthyretin (TTR) Amyloid Deposits Following Treatment with an RNAi Therapeutic in an Animal Model of TTR-Mediated Amyloidosis (ATTR)
	April 20, 2010
	Momenta Pharmaceuticals Announces Presentation of M402 Preclinical Data at Upcoming AACR Meeting
	April 15, 2010
	Regulus Therapeutics Presents New Pre-clinical Data on microRNA Therapeutics for Diabetes
	April 15, 2010
	Cubist Pharmaceuticals 1Q10 Total Net Revenues Up 19% to $144.1 Million
	April 15, 2010
	RIB-X TO PRESENT DATA ON DELAFLOXACIN AT EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES
	April 12, 2010
	Momenta Pharmaceuticals Announces Presentation of Preclinical Data on the Anti-Cancer Properties of M402 at AACR Meeting
	April 09, 2010
	Cubist Pharmaceuticals Enrolls 1st Subject in Phase 2 Trial for Therapy to Treat Clostridium Difficile-Associated Diarrhea, or CDAD
	April 08, 2010
	Momenta Pharmaceuticals Announces Publication of the M118 EMINENCE Clinical Trial Results in Circulation
	April 07, 2010
	Alnylam Announces Grant of New United States Patent Broadly Covering RNAi Therapeutics
	April 07, 2010
	Alnylam Announces Additional Grant of Tuschl II Patent in Japan
	March 31, 2010
	Cubist Pharmaceuticals to End Development of CB-500,929
	March 31, 2010
	Regulus Therapeutics and Collaborators Publish Pre-clinical In Vivo Efficacy Data on microRNA Therapeutics targeting microRNA-10b in Models of Breast Cancer Metastasis
	March 29, 2010
	59% of Physicians Think the Quality of Medicine in America will Decline in the Next Five Years According to athenahealth and Sermo 'Physician Sentiment Index'
	March 25, 2010
	Hudson Headwaters Health Network Goes Live on athenaClinicals to Support Patient-Centered Medical Home Initiative
	March 23, 2010
	RIB-X APPOINTS MARK LEUCHTENBERGER AS PRESIDENT AND CEO
	March 23, 2010
	Alnylam Completes Key Technology Transfer Objectives in its Takeda Alliance and Earns $20 Million Payment
	March 23, 2010
	athenahealth Improves Patient and Physician Practice Interactions with Launch of athenaCommunicator
	March 22, 2010
	Regulus Announces U.S. Allowance of Stanford Patent Application Covering miR-181a Function in Immune Cells
	March 17, 2010
	athenahealth, Inc. Reports Fourth Quarter and Full Year 2009 Results
	March 15, 2010
	Cubist Pharmaceuticals President and CEO Michael Bonney Honored by Massachusetts Biotechnology Council with its 2010 Innovative Leadership Award
	March 15, 2010
	Alnylam and Collaborators Present New Pre-Clinical Research on RNAi Therapeutics Targeting PCSK9
	March 15, 2010
	Alnylam to Webcast Presentation at the 22nd Annual ROTH OC Growth Stock Conference
	March 09, 2010
	Alnylam to Webcast Presentation at Cowen and Company's 30th Annual Health Care Conference
	March 03, 2010
	athenahealth and Falcon Launch Integrated Web-Based Electronic Health Record and Practice Management Platform for Nephrology
	March 03, 2010
	Momenta Pharmaceuticals to Present at The Cowen and Company 30th Annual Healthcare Conference
	March 03, 2010
	Alnylam Provides Update on Ongoing Litigation Regarding the Tuschl I Patent Series
	March 02, 2010
	athenahealth and Sermo Partner with a Common Goal: Enabling Physicians to Leverage Technology to Improve Patient Care
	March 01, 2010
	PANGU BIOPHARMA, ATYR PHARMA’S SUBSIDIARY IN HONG KONG, RECEIVES NEW RESEARCH GRANT FROM HONG KONG INNOVATION AND TECHNOLOGY COMMISSION
	March 01, 2010
	Alnylam to Webcast RNAi Roundtable on Thursday, March 4, 2010
	February 26, 2010
	Healthcare industry veteran Glenn Tobin joins CodeRyte, Inc.
	February 26, 2010
	Alnylam Pharmaceuticals Reports Fourth Quarter and 2009 Financial Results
	February 25, 2010
	Regulus Therapeutics and GlaxoSmithKline Establish New Collaboration to Develop and Commercialize microRNA Therapeutics Targeting miR-122
	February 25, 2010
	athenahealth, Inc. Postpones Fourth Quarter and Fiscal Year 2009 Earnings Release
	February 25, 2010
	Alnylam Pharmaceuticals Reports Fourth Quarter and 2009 Financial Results
	February 25, 2010
	US Oncology announces expanded educational resources to cancer patients through new affiliations with CURE & NexCura
	February 24, 2010
	Alnylam Selected as One of the 50 Most Innovative Companies in the World by MIT's Technology Review
	February 24, 2010
	Cubist Pharmaceuticals Appoints Lonnie Moulder to its Board of Directors
	February 22, 2010
	Alnylam Initiates Phase IIb Clinical Trial of ALN-RSV01 in Adult Lung Transplant Patients Infected with Respiratory Syncytial Virus (RSV) Infection
	February 22, 2010
	athenahealth Named to Fast Company Magazine's 'Fast 50' List of World's Most Innovative Companies
	February 18, 2010
	Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results
	February 18, 2010
	YALE UNIVERSITY PROFESSOR AND RIB-X CO-FOUNDER DISCOVERS NOVEL RIBOSOME ANTIBIOTIC STRUCTURES THAT MAY LEAD TO NEW TREATMENTS FOR DRUG-RESISTANT INFECTIONS
	February 16, 2010
	Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2009
	February 11, 2010
	SironaHealth Launches Web-based Audio Health Library as Part of Their 24 x 7 Nurse Advice Line Service
	February 09, 2010
	Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics
	February 08, 2010
	Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year Ended 2009 Financial Results
	February 04, 2010
	athenahealth, Inc. Announces Fourth Quarter and Full-Year 2009 Earnings Conference Call
	February 04, 2010
	AccentCare Expands to Colorado
	February 02, 2010
	Alnylam to Webcast Presentation at The 12th Annual BIO CEO & Investor Conference
	February 01, 2010
	Momenta Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
	January 29, 2010
	Day Kimball Healthcare Selects athenahealth to Implement New Electronic Health Record Platform
	January 26, 2010
	Regulus, Alnylam and Isis Announce U.S. Allowance of Tuschl III Patent Application Covering miR-21
	January 25, 2010
	Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million
	January 21, 2010
	athenahealth Named 'Business of the Decade' by the Boston Business Journal
	January 21, 2010
	RIB-X APPOINTS MEDIMMUNE'S PETER GREENLEAF TO BOARD
	January 20, 2010
	BIO Ventures for Global Health Chosen as Administrator of Intellectual Property Pool Involving GSK and Alnylam as Participants
	January 20, 2010
	Alnylam and Collaborators Discover Additional Class of Novel Lipid Nanoparticles with Markedly Improved In Vivo Potency for RNAi Therapeutics
	January 19, 2010
	Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium
	January 19, 2010
	Regulus Therapeutics Present New Pre-clinical Data from Multiple Therapeutic Programs at Keystone Symposium
	January 15, 2010
	Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
	January 11, 2010
	Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
	January 11, 2010
	Banner Health Improves Early Identification and Treatment of Severe Sepsis
	January 11, 2010
	athenahealth Names Timothy M. Adams as New Chief Financial Officer
	January 11, 2010
	New Philips VISICU Program Provides ICU Length of Stay Management to Improve ICU Capacity and Throughput
	January 11, 2010
	Alnylam and Collaborators Discover Key Mechanism for Delivery of RNAi Therapeutics
	January 08, 2010
	Cubist Pharmaceuticals and the New England Patriots Radio Network Recognize Innovative Science Teachers
	December 28, 2009
	University of Mississippi Health Care Implements Philips VISICU eICU® Program
	December 22, 2009
	SironaHealth Bolsters Customer Relations Team by Hiring Amy Johnson-Morin as Account Manager
	December 17, 2009
	Regulus Therapeutics Receives Exclusive License for Intellectual Property on Immuno-inflammatory microRNAs from the California Institute of Technology
	December 17, 2009
	athenahealth Receives Top National Ranking for Small Physician Practice Category in 2009 KLAS Report for Practice Management Services
	December 17, 2009
	Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
	December 15, 2009
	Cubist Pharmaceuticals to Acquire Calixa Therapeutics
	December 14, 2009
	Research Led by Co-founders of aTyr Pharma Illustrates Mechanism for Multifunctionality of a Single Protein
	December 14, 2009
	Trial Date Set for CUBICIN(R) Patent Litigation
	December 11, 2009
	TelaDoc Medical Services Secures $9M Funding Led By HLM Venture Partners
	December 09, 2009
	Regulus Therapeutics Inc. presents: 'MicroRNA: The Year in Review and a Look Ahead'
	December 09, 2009
	Cubist Pharmaceuticals Closes Enrollment Early in CONSERV(TM)-1 and CONSERV-2 Ph. 2 Trials for CB-500,929 (Ecallantide), in Development as Therapy to Reduce Bleeding in On-Pump Cardiac Surgery
	December 03, 2009
	Alnylam to Webcast Presentation at Piper Jaffray 21st Annual Health Care Conference
	November 24, 2009
	Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer
	November 18, 2009
	U.S. Patent and Trademark Office Grants athenahealth, Inc., a Patent for its Practice Management and Billing Automation System
	November 13, 2009
	Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day
	November 12, 2009
	The Boston Globe names Cubist to Globe 100's Top Places to Work '09
	November 09, 2009
	Alnylam to Webcast R&D Day on Thursday, November 12, 2009
	November 09, 2009
	Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting
	November 05, 2009
	Alnylam and Roche Advance RNAi Therapeutic Collaboration Phase of Landmark 2007 Alliance
	November 04, 2009
	Alnylam Pharmaceuticals Reports Third Quarter 2009 Financial Results
	November 04, 2009
	Cubist Pharmaceuticals to Present at Lazard Capital Markets 6th Annual Healthcare Conference
	November 03, 2009
	Alnylam Presents New Pre-Clinical Data on ALN-TTR, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
	November 02, 2009
	Alnylam to Webcast Conference Call Discussing Third Quarter 2009 Financial Results
	October 30, 2009
	Alnylam to Participate in Major Cardiovascular Disease Research Grant Awarded to Scientists at University of Pennsylvania
	October 29, 2009
	athenahealth, Inc. Reports Third Quarter 2009 Results
	October 29, 2009
	Regulus Announces U.S. Allowance of Fundamental microRNA Therapeutics Patent Application
	October 28, 2009
	Alnylam Grants KOKEN License to Kreutzer-Limmer Patents for the RNA Interference (RNAi) Research Products Market
	October 27, 2009
	Philips VISICU eICU Program Facilitates Hospital Management of Surge Capacity Demand
	October 26, 2009
	ASANTE HEALTH SYSTEM PARTNERS WITH ACCENTCARE, INC. TO PROVIDE HOME HEALTH CARE SERVICES
	October 25, 2009
	athenahealth Completes Acquisition of Anodyne Health Partners, Inc.
	October 19, 2009
	Cubist Pharmaceuticals 3rd Quarter Total Net Revenues Up 28%
	October 15, 2009
	Dr. Floyd Bloom Joins aTyr Pharma's Scientific Advisory Board
	October 14, 2009
	Danbury Office of Physician Services Selects athenaCollector
	October 12, 2009
	Cubist Pharmaceuticals Announces Third Quarter 2009 Earnings Call
	October 08, 2009
	Cubist Pharmaceuticals Wins Top Honors in the Sixth Annual Team Massachusetts Economic Impact Awards
	October 07, 2009
	aTyr Pharma to Present at Biopartnering Europe Conference
	October 05, 2009
	Alnylam to Webcast Presentation at the Fourth Annual JMP Securities Healthcare Focus Conference
	October 05, 2009
	athenahealth to Acquire Anodyne Health Partners, Inc.
	October 05, 2009
	Cubist Pharmaceuticals Announces Enhanced Careers Section of Corporate Website
	September 29, 2009
	Inova Health System Responds to Simulated Terrorist Emergency
	September 28, 2009
	Professor Osamu Nureki Joins aTyr Pharma’s Scientific Advisory Board
	September 28, 2009
	aTyr Pharma to Present at Japan Biopharma Partnering Conference
	September 22, 2009
	aTyr Pharma to Present at Biopharm America 2009
	September 18, 2009
	Regulus, Alnylam, and Isis Announce First microRNA Patent Grant in Japan from Tuschl III Patent Series
	September 17, 2009
	Alnylam to Webcast Presentation at UBS Global Life Sciences Conference
	September 16, 2009
	Regulus Therapeutics Appoints Hubert C. Chen, M.D., Vice President of Translational Medicine
	September 16, 2009
	athenahealth Launches Federal Stimulus Bonus Payment Guarantee Program for Physicians Nationwide
	September 15, 2009
	Alnylam and Medtronic Present New Late-Stage Pre-clinical Data on ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease
	September 15, 2009
	Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology
	September 10, 2009
	Alnylam to Webcast Presentation at Morgan Stanley Global Healthcare Conference
	September 09, 2009
	Alnylam Announces Allowance in Europe of New Fundamental Patent Broadly Covering RNAi Therapeutics in Oncology
	September 09, 2009
	US Patent Issued for aTyr Pharma Novel Biotherapeutic
	September 08, 2009
	Alnylam to Webcast Presentations at the Rodman & Renshaw Global Investment Conference and the Thomas Weisel Partners Healthcare Conference 2009
	September 03, 2009
	Cubist Pharmaceuticals to Present at September Investor Conferences
	September 01, 2009
	athenahealth Receives 2009 Best Places to Work in Maine Award
	September 01, 2009
	Rib-X Pharmaceuticals Antibiotic Drug Discovery Platform Discovers Novel Compounds with Activity Against Key Multiple Drug Resistant Gram-negative Bacteria
	August 31, 2009
	Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009
	August 31, 2009
	Geisinger to Launch eICU® Program
	August 25, 2009
	Alnylam Provides Organizational Update
	August 21, 2009
	Professor Nancy Ip Joins aTyr Pharma’s Scientific Advisory Board
	August 17, 2009
	Cubist Pharmaceuticals and the New England Patriots Radio Network Team Up to Recognize Innovative Science Teachers
	August 13, 2009
	CapitalSource and AccentCare Announce Closing of $35MM Financing
	August 13, 2009
	Alnylam and Regulus Receive Notice of Allowance from United States Patent and Trademark Office for New Patent Covering microRNA Therapeutics
	August 11, 2009
	Accentcare Named one of the Ten Fastest Growing Startups in Southern California
	August 07, 2009
	Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2009
	August 06, 2009
	Alnylam and Tekmira Participate in New Research Collaboration
	August 06, 2009
	athenahealth, Inc. Reports Second Quarter 2009 Results
	August 05, 2009
	Cubist Pharmaceuticals to Present at Canaccord Adams 29th Annual Global Growth Conference
	August 04, 2009
	Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumoniae
	August 04, 2009
	Professor Bruce Beutler Joins aTyr Pharma’s Scientific Advisory Board
	August 03, 2009
	athenahealth Co-Founder Appointed Chief Technology Officer for U.S. Department of Health and Human Services
	August 03, 2009
	Alnylam to Webcast Conference Call Discussing Second Quarter 2009 Financial Results
	July 30, 2009

Current Portfolio News

Archive Portfolio News